公司新闻 - 亚科因（Abbkine）—服务于细胞和蛋白研究全球用户

公司新闻 - 亚科因（Abbkine）—服务于细胞和蛋白研究全球用户

首页
技术中心
产品文献

或

货号	产品名称	文献标题	IF	杂志名称
ABL1060	COX IV小鼠单克隆抗体（14Y2）	Inhibition of AKT induces p53/SIRT6/PARP1-dependent parthanatos to suppress tumor growth	4	Cell Commun Signal
ABL1060	COX IV小鼠单克隆抗体（14Y2）	XRCC2-Deficient Cells are Highly Sensitive to 5-Fluorouracil in Colorectal Cancer	5	Cell Physiol Biochem
ABL1060	COX IV小鼠单克隆抗体（14Y2）	Genomic expression profiles in cumulus cells derived from germinal vesicle and MII mouse oocytes	2	Reproduction, Fertility and Development
ABL1060	COX IV小鼠单克隆抗体（14Y2）	Construction of the IRES-based Vector for Multiple Gene Co-expression		China Biotechnology
ABL1060	COX IV小鼠单克隆抗体（14Y2）	Angiotensin-converting enzyme 2 activator diminazene aceturate prevents lipopolysaccharide-induced inflammation by inhibiting MAPK and NF-κB pathways in human retinal pigment epithelium	6	Journal of neuroinflammation
ABL1060	COX IV小鼠单克隆抗体（14Y2）	Proteus mirabilis Vesicles Induce Mitochondrial Apoptosis by Regulating miR96-5p/Abca1 to Inhibit Osteoclastogenesis and Bone Loss	8	Frontiers in immunology
ABL1070	组蛋白H3小鼠单克隆抗体（2D10）	The negative effect of silica nanoparticles on adipogenic differentiation of human mesenchymal stem cells	27	Materials Science and Engineering: C
ABL1070	组蛋白H3小鼠单克隆抗体（2D10）	Leptin/leptinR-kisspeptin/kiss1r-GnRH pathway reacting to regulate puberty onset during negative energy balance	3	Life sciences
ABL1070	组蛋白H3小鼠单克隆抗体（2D10）	Mitochondrial Division Inhibitor 1 Ameliorates Mitochondrial Injury, Apoptosis, and Motor Dysfunction After Acute Spinal Cord Injury in Rats	3	Neurochemical research
ABL1070	组蛋白H3小鼠单克隆抗体（2D10）	Hydrogen Sulfide Alleviates Lipid Peroxidation-Mediated Carbonyl Stress in Uranium-Intoxicated Kidney Cells via Nrf2/ARE Signaling.	4	Biomedical and Environmental Sciences

首页上一页 30 31 32 33 34 35 下一页尾页

赋能细胞研究与治疗 Enabling cell research and therapy

联系我们

全国服务热线： 400-6800-830

订购邮箱： service@abbkine.com

联系地址：武汉光谷生物医药加速器17号楼1号房2-3层

友情链接：

Copyright ©Abbkine Scientific Co., Ltd- 鄂ICP备10204150号-5

意见反馈

 在线咨询

扫码关注

微信公众号

返回顶部